Posts

Oncology Institute (NASDAQ:TOI) Now Covered by Analysts...

Investment analysts at BTIG Research began coverage on shares of Oncology Instit...

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives Hold Rat...

Needham & Company LLC reiterated their hold rating on shares of Verrica Pharmace...

Equities Analysts Set Expectations for IP Q2 Earnings

International Paper (NYSE:IP – Free Report) – Stock analysts at Zacks Research l...

Zacks Small Cap Issues Optimistic Estimate for ENSC Ear...

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Free Report) – Stock analysts at Zacks ...

Q2 Earnings Estimate for LXRX Issued By Leerink Partnrs

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Stock analysts at Le...

Q2 EPS Forecast for Illinois Tool Works Reduced by Analyst

Illinois Tool Works Inc. (NYSE:ITW – Free Report) – Research analysts at Zacks R...

Equities Analysts Offer Predictions for EW Q2 Earnings

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Research analysts at Zacks Re...

Roth Capital Brokers Increase Earnings Estimates for MBRX

Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at Roth Capital u...

Leerink Partnrs Predicts Weaker Earnings for MacroGenics

MacroGenics, Inc. (NASDAQ:MGNX – Free Report) – Equities researchers at Leerink ...

Q2 EPS Forecast for Daré Bioscience Lifted by Analyst

Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Equities research analysts a...

Wedbush Predicts Increased Earnings for Fate Therapeutics

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Analysts at Wedbush increa...

Q2 EPS Estimate for Kezar Life Sciences Raised by Analyst

Kezar Life Sciences, Inc. (NASDAQ:KZR – Free Report) – Equities researchers at W...

Q2 Earnings Estimate for Groupon Issued By Northland Capmk

Groupon, Inc. (NASDAQ:GRPN – Free Report) – Investment analysts at Northland Cap...

Q2 EPS Estimate for Inovio Pharmaceuticals Cut by Analyst

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Equities researchers a...

What is HC Wainwright’s Estimate for Genmab A/S Q2 Earn...

Genmab A/S (NASDAQ:GMAB – Free Report) – Investment analysts at HC Wainwright cu...

Research Analysts Offer Predictions for MNPR Q2 Earnings

Monopar Therapeutics Inc. (NASDAQ:MNPR – Free Report) – Stock analysts at Brookl...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.